Hospital
Reedley Community Hospital
Reedley Community Hospital was paid $15.46M by Medicaid between Jan 2018 and Dec 2024, across 428 billing codes. Its largest line is 0450, Emergency room services — 24% of everything it billed.
33Billing provider infoREEDLEY COMMUNITY HOSPITAL
REEDLEY, CA 93654
REEDLEY, CA 93654
33aNPI1336167550assigned 07/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.46M
24GClaims1,988,259
24DCodes billed428
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#142 of 410
Median peer was paid$6.90M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 173,565 | $2.00M | |
| 2019 | 214,264 | $1.80M | |
| 2020 | 184,426 | $1.53M | |
| 2021 | 289,044 | $1.97M | |
| 2022 | 329,113 | $2.73M | |
| 2023 | 402,952 | $2.83M | |
| 2024incomplete | 394,895 | $2.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 24% | 143,100 | 129,182 | $3.73M |
| 99199 | Unlisted special service, procedure or report | 13% | 16,425 | 14,677 | $2.00M |
| 80053 | Comprehensive metabolic panel | 3.6% | 68,232 | 63,970 | $559K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 3.4% | 6,224 | 3,907 | $523K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.3% | 13,548 | 13,203 | $507K |
| Z7502 | 2.4% | 10,151 | 9,891 | $373K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 28,282 | 26,185 | $366K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.1% | 6,468 | 6,348 | $321K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 16,434 | 16,079 | $276K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 17,219 | 16,098 | $269K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 9,626 | 9,185 | $233K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 4,888 | 4,039 | $214K |
416 more codes
| 80306 | 1.3% | 12,124 | $205K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 7,540 | $187K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 6,660 | $187K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.2% | 14,449 | $178K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 13,340 | $174K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12,901 | $150K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 69,165 | $141K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25,699 | $136K |
| J3490 | Unclassified drugs | <1% | 30,616 | $130K |
| 99283 | Emergency room visit (moderate) | <1% | 2,259 | $123K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 12,466 | $119K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 9,863 | $114K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 2,126 | $114K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 920 | $110K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 7,731 | $106K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 17,279 | $102K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12,679 | $102K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,795 | $96K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 3,656 | $96K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 17,764 | $95K |
| 99284 | Emergency room visit (serious) | <1% | 1,833 | $93K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,427 | $88K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,114 | $85K |
| 81025 | <1% | 27,660 | $78K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 150,521 | $73K |
| 76830 | Ultrasound, transvaginal | <1% | 6,123 | $72K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,267 | $71K |
| 81001 | <1% | 41,933 | $68K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,641 | $68K |
| 73610 | <1% | 6,414 | $67K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 18,084 | $65K |
| 76801 | <1% | 5,430 | $63K | |
| 73562 | <1% | 7,145 | $62K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,583 | $61K |
| 0270 | <1% | 72,727 | $60K | |
| 73630 | <1% | 7,890 | $58K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,890 | $58K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,269 | $57K |
| 86900 | <1% | 5,165 | $55K | |
| 71045 | Radiologic examination, chest; single view | <1% | 15,644 | $52K |
| 73130 | <1% | 5,261 | $51K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,512 | $50K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17,323 | $48K |
| 86901 | <1% | 5,167 | $47K | |
| 73030 | <1% | 6,405 | $44K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 10,076 | $44K |
| 59025 | Fetal non-stress test | <1% | 9,433 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 10,849 | $42K |
| 76770 | <1% | 2,206 | $39K | |
| 59514 | <1% | 252 | $37K | |
| 84702 | <1% | 5,258 | $33K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 548 | $32K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,689 | $32K |
| 72100 | <1% | 4,064 | $31K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,499 | $30K |
| 84484 | <1% | 13,098 | $30K | |
| 73110 | <1% | 3,390 | $30K | |
| 0760 | <1% | 3,506 | $29K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,868 | $29K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,902 | $29K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,089 | $28K |
| 72110 | <1% | 3,479 | $27K | |
| 80061 | Lipid panel | <1% | 15,761 | $27K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,345 | $27K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,416 | $27K |
| 83690 | <1% | 14,881 | $26K | |
| 99285 | Emergency room visit (most serious) | <1% | 536 | $26K |
| 83880 | <1% | 4,056 | $25K | |
| 0250 | <1% | 810 | $25K | |
| 90715 | <1% | 2,013 | $24K | |
| 82962 | <1% | 7,678 | $24K | |
| 76642 | <1% | 2,216 | $23K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,197 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24,670 | $22K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,740 | $22K |
| 74018 | <1% | 3,105 | $21K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,615 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 361 | $20K |
| Z9725 | <1% | 439 | $19K | |
| 87186 | <1% | 4,557 | $19K | |
| 76536 | <1% | 1,613 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,828 | $19K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,843 | $18K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 543 | $18K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,078 | $18K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,234 | $18K |
| 81003 | <1% | 11,248 | $18K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 271 | $16K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,645 | $16K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,681 | $16K |
| 87077 | <1% | 4,691 | $16K | |
| 87040 | <1% | 5,119 | $16K | |
| 73080 | <1% | 1,509 | $16K | |
| 77066 | Tomosynthesis, mammo | <1% | 731 | $15K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 67,619 | $15K |
| 72040 | <1% | 1,443 | $15K | |
| 76857 | <1% | 1,876 | $15K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 321 | $14K |
| 73502 | <1% | 1,533 | $13K | |
| 74019 | <1% | 1,981 | $13K | |
| 93971 | <1% | 781 | $13K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,365 | $12K |
| 87081 | <1% | 1,660 | $11K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 6,859 | $10K |
| 72050 | <1% | 1,148 | $10K | |
| 73564 | <1% | 3,020 | $10K | |
| 83605 | <1% | 3,742 | $10K | |
| 86481 | <1% | 799 | $9K | |
| 72131 | <1% | 185 | $9K | |
| 86850 | <1% | 1,709 | $9K | |
| 71250 | <1% | 332 | $9K | |
| 84439 | <1% | 4,709 | $9K | |
| 80074 | <1% | 784 | $9K | |
| 99070 | <1% | 16,788 | $9K | |
| 76870 | <1% | 605 | $8K | |
| 99242 | <1% | 900 | $8K | |
| 86780 | <1% | 2,406 | $8K | |
| 94664 | <1% | 2,687 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 311 | $8K |
| 72072 | <1% | 854 | $8K | |
| 73140 | <1% | 688 | $8K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,794 | $7K |
| 73590 | <1% | 992 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,016 | $7K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 10,551 | $7K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 81 | $6K |
| 73090 | <1% | 696 | $6K | |
| 84703 | <1% | 2,255 | $6K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 127 | $6K |
| 1159F | <1% | 129,999 | $6K | |
| Z7610 | <1% | 4,099 | $6K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,851 | $6K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,059 | $6K |
| 82607 | <1% | 2,844 | $5K | |
| 20610 | <1% | 849 | $5K | |
| 70486 | <1% | 136 | $5K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 471 | $5K |
| 0324 | <1% | 210 | $5K | |
| 82150 | <1% | 3,012 | $5K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,122 | $5K |
| 82731 | <1% | 580 | $5K | |
| 0403 | <1% | 68 | $5K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 125 | $5K |
| 83735 | <1% | 3,032 | $5K | |
| 84153 | <1% | 1,266 | $4K | |
| 85610 | <1% | 4,794 | $4K | |
| 3008F | <1% | 86,657 | $4K | |
| 12001 | <1% | 235 | $4K | |
| 86235 | <1% | 690 | $4K | |
| 77065 | Tomosynthesis, mammo | <1% | 227 | $4K |
| 80143 | <1% | 258 | $4K | |
| 83970 | <1% | 330 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 431 | $4K |
| 86038 | <1% | 1,893 | $4K | |
| 47562 | <1% | 34 | $4K | |
| 0300 | <1% | 143 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,794 | $3K |
| J1815 | Injection, insulin, per 5 units | <1% | 455 | $3K |
| 86803 | <1% | 2,155 | $3K | |
| 0360 | <1% | 47 | $3K | |
| 82728 | <1% | 1,389 | $3K | |
| 86140 | <1% | 3,196 | $3K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 544 | $3K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 664 | $3K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 710 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,394 | $3K |
| 82274 | <1% | 790 | $3K | |
| 82746 | <1% | 738 | $3K | |
| 84550 | <1% | 2,503 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 252 | $3K |
| 82805 | <1% | 330 | $2K | |
| 97163 | <1% | 459 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 223 | $2K |
| 1160F | <1% | 103,225 | $2K | |
| 0259 | <1% | 138 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,347 | $2K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 451 | $2K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,504 | $2K |
| 82043 | <1% | 3,268 | $2K | |
| 73560 | <1% | 361 | $2K | |
| 0510 | <1% | 323 | $2K | |
| 86160 | <1% | 864 | $2K | |
| 87400 | <1% | 397 | $2K | |
| 73620 | <1% | 330 | $2K | |
| 85730 | <1% | 1,474 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 62 | $2K |
| 83516 | <1% | 1,131 | $2K | |
| 84132 | <1% | 116 | $2K | |
| 99243 | <1% | 286 | $2K | |
| 82550 | <1% | 1,426 | $2K | |
| 85027 | <1% | 1,976 | $2K | |
| 86141 | <1% | 718 | $2K | |
| 73221 | <1% | 51 | $2K | |
| 87340 | <1% | 1,387 | $2K | |
| 86147 | <1% | 229 | $2K | |
| 0729 | <1% | 275 | $2K | |
| 85652 | <1% | 3,461 | $2K | |
| 84481 | <1% | 551 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,465 | $2K |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 578 | $1K |
| 86317 | <1% | 797 | $1K | |
| 84436 | <1% | 896 | $1K | |
| 84466 | <1% | 495 | $1K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 43 | $1K |
| 82247 | <1% | 421 | $1K | |
| 82570 | <1% | 1,679 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 258 | $1K |
| 86635 | <1% | 282 | $1K | |
| 87210 | <1% | 836 | $1K | |
| 71101 | <1% | 53 | $1K | |
| 83540 | <1% | 1,028 | $1K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 64 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 11,333 | $1K |
| 86480 | <1% | 114 | $1K | |
| 30520 | <1% | 12 | $1K | |
| 97014 | <1% | 2,411 | $1K | |
| 82248 | <1% | 937 | $1K | |
| 83013 | <1% | 157 | $970.53 | |
| 86225 | <1% | 547 | $947.14 | |
| 84156 | <1% | 1,384 | $853.46 | |
| 82553 | <1% | 371 | $827.15 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 441 | $825.46 |
| 80076 | <1% | 500 | $810.76 | |
| 0320 | <1% | 34 | $810.41 | |
| 84479 | <1% | 648 | $790.38 | |
| 86376 | <1% | 227 | $786.84 | |
| 74022 | <1% | 44 | $786.50 | |
| 87807 | <1% | 316 | $785.73 | |
| 86431 | <1% | 897 | $769.64 | |
| 51798 | <1% | 119 | $686.62 | |
| 87070 | <1% | 235 | $669.17 | |
| 86039 | <1% | 299 | $635.50 | |
| 85379 | <1% | 290 | $615.21 | |
| 86762 | <1% | 220 | $605.02 | |
| 10060 | <1% | 24 | $578.44 | |
| 80179 | <1% | 151 | $576.42 | |
| 84100 | <1% | 564 | $566.55 | |
| 97010 | <1% | 1,692 | $521.22 | |
| 86200 | <1% | 401 | $513.67 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 112 | $498.76 |
| 97803 | <1% | 1,125 | $496.09 | |
| 82785 | <1% | 270 | $476.35 | |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 15 | $476.34 |
| 29125 | <1% | 75 | $440.43 | |
| 86146 | <1% | 108 | $436.31 | |
| 12011 | <1% | 38 | $426.38 | |
| 82948 | <1% | 3,237 | $426.31 | |
| 84112 | <1% | 236 | $425.91 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 135 | $416.25 |
| 70360 | <1% | 88 | $411.95 | |
| 97750 | <1% | 212 | $382.20 | |
| 82010 | <1% | 191 | $381.22 | |
| 73522 | <1% | 44 | $374.49 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,123 | $348.38 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 26 | $329.30 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 71 | $318.73 |
| 73552 | <1% | 14 | $316.96 | |
| 87045 | <1% | 65 | $301.14 | |
| 90688 | <1% | 237 | $283.56 | |
| 77080 | <1% | 57 | $280.48 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 102 | $278.15 |
| 3078F | <1% | 14,529 | $275.30 | |
| 86003 | <1% | 69 | $262.24 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,374 | $261.00 |
| 0160 | <1% | 28 | $233.88 | |
| 72081 | <1% | 27 | $232.60 | |
| 84146 | <1% | 98 | $219.06 | |
| 36600 | <1% | 28 | $219.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 15 | $209.48 |
| 99460 | <1% | 97 | $201.23 | |
| 72082 | <1% | 55 | $186.72 | |
| 84403 | <1% | 30 | $186.61 | |
| 82784 | <1% | 157 | $184.04 | |
| 83001 | <1% | 99 | $179.56 | |
| 3077F | <1% | 2,654 | $162.80 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 15 | $152.14 |
| 72070 | <1% | 54 | $142.99 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 21 | $142.62 |
| 85018 | <1% | 4,149 | $135.37 | |
| 86704 | <1% | 257 | $134.55 | |
| 97802 | <1% | 290 | $121.40 | |
| 82950 | <1% | 207 | $119.45 | |
| 86015 | <1% | 52 | $119.33 | |
| 3074F | <1% | 11,991 | $118.90 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 55 | $112.99 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 876 | $107.66 |
| 86430 | <1% | 109 | $104.56 | |
| 82951 | <1% | 82 | $103.84 | |
| 82947 | <1% | 149 | $99.73 | |
| 3079F | <1% | 5,741 | $97.00 | |
| 59425 | <1% | 727 | $96.76 | |
| 83520 | <1% | 15 | $92.16 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 321 | $87.64 |
| 83014 | <1% | 133 | $84.96 | |
| 83986 | <1% | 45 | $82.82 | |
| 99205 | Prolong outpt/office vis | <1% | 40 | $82.70 |
| 85045 | <1% | 66 | $72.33 | |
| 83655 | <1% | 43 | $72.32 | |
| 90656 | <1% | 1,769 | $72.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 29 | $71.08 |
| 96367 | <1% | 12 | $69.80 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 175 | $67.16 |
| 11721 | <1% | 1,176 | $66.26 | |
| 84295 | <1% | 102 | $65.60 | |
| 72170 | <1% | 14 | $65.00 | |
| 0710 | <1% | 14 | $64.02 | |
| 87147 | <1% | 44 | $63.95 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 42 | $63.16 |
| 85613 | <1% | 68 | $60.94 | |
| 82435 | <1% | 99 | $60.71 | |
| 86812 | <1% | 12 | $58.50 | |
| 73060 | <1% | 13 | $58.14 | |
| 72220 | <1% | 15 | $55.98 | |
| 97804 | <1% | 31 | $55.64 | |
| 84480 | <1% | 13 | $54.42 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 13 | $53.40 |
| 82140 | <1% | 12 | $48.84 | |
| 94760 | <1% | 36 | $48.12 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 25 | $46.47 |
| 90686 | <1% | 8,232 | $45.00 | |
| 84460 | <1% | 51 | $43.60 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 82 | $41.02 |
| 83002 | <1% | 40 | $40.71 | |
| 0012A | <1% | 16 | $40.00 | |
| 84165 | <1% | 12 | $34.36 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 15 | $33.84 |
| 84450 | <1% | 40 | $32.65 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 12 | $32.56 |
| 43249 | <1% | 12 | $30.78 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 272 | $25.73 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 29 | $23.50 |
| 99201 | <1% | 626 | $22.90 | |
| 87205 | <1% | 27 | $21.79 | |
| 86308 | <1% | 12 | $20.00 | |
| 29515 | <1% | 12 | $18.00 | |
| 98940 | <1% | 1,421 | $16.72 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 21 | $11.28 |
| 86800 | <1% | 13 | $10.18 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,435 | $9.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,926 | $9.00 |
| 90670 | <1% | 2,192 | $9.00 | |
| 90723 | <1% | 1,475 | $9.00 | |
| 90680 | <1% | 759 | $9.00 | |
| 83615 | <1% | 12 | $8.72 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 29 | $7.97 |
| 82952 | <1% | 27 | $6.12 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 461 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 125 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 449 | $0.00 |
| 90658 | 0% | 68 | $0.00 | |
| 90707 | 0% | 764 | $0.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 1,420 | $0.00 |
| 92552 | 0% | 3,765 | $0.00 | |
| 90633 | 0% | 1,027 | $0.00 | |
| 11056 | 0% | 78 | $0.00 | |
| 81002 | 0% | 204 | $0.00 | |
| 99442 | 0% | 1,770 | $0.00 | |
| H1000 | Prenatal care, at-risk assessment | 0% | 928 | $0.00 |
| 99152 | 0% | 30 | $0.00 | |
| 90734 | 0% | 152 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 83 | $0.00 |
| 3046F | 0% | 268 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 199 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 51 | $0.00 |
| 90649 | 0% | 13 | $0.00 | |
| 99401 | 0% | 204 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 102 | $0.00 |
| 3051F | 0% | 25 | $0.00 | |
| 92553 | 0% | 116 | $0.00 | |
| 86256 | 0% | 16 | $0.00 | |
| 86787 | 0% | 12 | $0.00 | |
| 90644 | 0% | 12 | $0.00 | |
| 90700 | 0% | 52 | $0.00 | |
| 87209 | 0% | 12 | $0.00 | |
| 90685 | 0% | 210 | $0.00 | |
| 99497 | 0% | 29 | $0.00 | |
| 87177 | 0% | 12 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 42 | $0.00 |
| G9774 | Patients who have had a hysterectomy | 0% | 80 | $0.00 |
| 97755 | 0% | 12 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 43 | $0.00 |
| 3075F | 0% | 4,274 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 1,050 | $0.00 |
| 90647 | 0% | 1,494 | $0.00 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 0% | 950 | $0.00 |
| 3044F | 0% | 1,458 | $0.00 | |
| 99406 | 0% | 58 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 516 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 133 | $0.00 |
| 90716 | 0% | 814 | $0.00 | |
| 96156 | 0% | 459 | $0.00 | |
| 99443 | 0% | 1,416 | $0.00 | |
| 90677 | 0% | 481 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 157 | $0.00 |
| 99441 | 0% | 621 | $0.00 | |
| G9964 | Patient received at least one well-child visit with a pcp during the performance period | 0% | 354 | $0.00 |
| 59430 | 0% | 311 | $0.00 | |
| 91301 | 0% | 37 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 134 | $0.00 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 0% | 1,850 | $0.00 |
| 0259R | 0% | 226 | $0.00 | |
| 90651 | 0% | 176 | $0.00 | |
| 3080F | 0% | 161 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 186 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 41 | $0.00 |
| 99462 | 0% | 12 | $0.00 | |
| 92250 | 0% | 63 | $0.00 | |
| 90620 | 0% | 42 | $0.00 | |
| 3052F | 0% | 28 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 14 | $0.00 |
| 86580 | 0% | 44 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 16 | $0.00 |
| 92551 | 0% | 14 | $0.00 | |
| 90636 | 0% | 17 | $0.00 | |
| 29581 | 0% | 31 | $0.00 | |
| 90696 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHORDARSON, HEIDAR (CHIEF FINANCIAL OFFICER)
Parent organizationADVENTIST HEALTH SYSTEM/WEST
| Provider | Location | Paid |
|---|---|---|
| Hanford Community Hospital | Hanford, CA | $37.77M |
| Adventist Health Tulare | Tulare, CA | $17.13M |
| Castle Medical Center | Kailua, HI | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.